Nanomaterials in Analytical ChemistryAs particle size approaches molecular dimensions, all properties of a material change, making nanomaterials useful for particular applications.Charles R. Martin and
David T. Mitchell Nanomaterials constitute an
emerging subdiscipline in the
chemical and materials sciences
(1, 2). Nanomaterials have numerous commercial and technological applications, including analytical chemistry (3-6); drug
delivery; bioencapsulation; and electronic,
optical, and mechanical devices. In addition, this field poses an important fundamental question--how do the electronic,
optical, and magnetic properties of a nanoscopic particle differ from those of a bulk
sample of the same material? This issue is
of particular importance because all properties of a material change as the particle size
approaches molecular dimensions and because it is often the unique properties of
the nanomaterial that make it useful for a
particular application.This Report deals with exploiting the unique properties of nanomaterials for bioanalytical chemistry, bioseparations, and bioimaging. Recent advances in analytical applications of colloidal particles will also be discussed. Finally, the template approach for preparing nanomaterials is described, and possible applications are reviewed. The objective of this Report is to introduce analytical chemists to the numerous applications of nanomaterials in chemical analysis and to encourage them to consider nanomaterials in their own research and development projects. Bioanalysis, bioseparations, and MRIThere is no universally agreed upon definition of when a small particle qualifies as a
nanoparticle. In our research group, we consider particles with at least one dimension
(d) Immunoagglutination. The use of
synthetic microparticles in bioanalysis originated in the mid-1950s, with the invention
of latex agglutination tests by Singer and
Plotz (7). These simple, ingenious tests
use suspended latex microparticles (diameter ~1 Latex agglutination tests have been developed for more than 100 analytes, including infectious disease agents and drugs of abuse (6). These tests are portable, simple to use, highly selective, and fast; they can also be quantitative. For example, there are agglutination assays that relate the intensity of light scattered by the agglutinated particles to the concentration of the analyte (6). Particles with truly nanoscopic dimensions have also been used in tests of this type, such as the Carter-Wallace home pregnancy test "First Response", which uses conventional micrometer-sized latex particles in conjunction with gold nanoparticles (less than 50-nm diameter) (6). Gold nanoparticles show a characteristic visible absorption band called the plasmon resonance absorption (8), which makes them pink. The micro- and nanoparticles are derivatized with antibodies to human chorionic gonadotrophin, a hormone released by pregnant women. When mixed with a urine sample containing this hormone, the micro- and nanoparticles are coagglutinated and the resulting clumps are colored pink. This example uses the gold nanoparticle as the indicator in a conventional microparticle-based agglutination test. In addition, nanoparticles have been used as replacements for micrometer-sized particles (4, 6, 9). For example, Medcalf et al. have developed an immunoturbidimetric assay for urine albumin, an indicator of kidney problems. Poly(vinylnaphthalene) particles (40-nm diameter) were coated with an outer layer of a chloromethylstyrene polymer, which was used to immobilize an antibody raised against human albumin. Agglutination in the presence of urine albumin was detected by measuring the change in absorbance caused by light scattering at 340 nm (9). Using nanoparticles in such assays offers several potential advantages. For example, suspensions of nanoparticles do not appreciably scatter visible light (6), which means that the background signal in a turbidimetric assay is lower than in tests that use milky-white suspensions of the microparticles (4). This results in lower detection limits (9). In addition, nanoparticles form more stable suspensions and are therefore less susceptible to self-agglomeration (4, 9). Colorimetric DNA detection. The plasmon resonance absorption of colloidal gold particles has recently been exploited in a proposed DNA-detection method (10). Mirkin and co-workers attached 13-nm-diameter gold nanoparticles to single-stranded oligonucleotides. The plasmon resonance absorbance for these particles has a maximum at 520 nm, and the particles appear red. When a linking oligonucleotide was added, the gold nanoparticles agglutinated, and the color changed from red to purple. To attach the single-stranded oligonucleotides to the gold nanoparticles, a gold sol was stirred with a solution of terminally thiolated, 28 base-pair DNA. The first 13 nucleotides served as a spacer from the nanoparticle surface; the last 15 were the recognition element for the target. Two different recognition-element sequences were used. It is important to note that many oligomers were attached to each gold particle (10). The target DNA was a 30 base-pair strand, the first 15 bases of which are complementary to the first recognition element, and the remaining 15 complementary to the second recognition element. When the target DNA was added to the modified colloidal suspension, the target linked the individual colloid particles into a polymeric network. Because the nanoparticles were now much closer together, the plasmon resonance band shifted, and the color changed. Although this detection method had not yet been optimized, the detection limit was 10 fmol for the target oligonucleotide. An additional benefit of this particular method is that it allows visual detection, especially if the sample is developed on a solid support such as a reversed-phase silica TLC plate (10). Superparamagnetic nanoparticles. The basic concept in magnetic bioseparations is to selectively bind the biomaterial of interest (e.g., a specific cell, protein, or DNA sequence) to a magnetic particle and then separate it from its surrounding matrix using a magnetic field. Nanoparticles of Fe3O4 with diameters in the 5-100 nm range are typically used for such separations. These particles are "superparamagnetic", meaning that they are attracted to a magnetic field but retain no residual magnetism after the field is removed (11). Therefore, suspended superparamagnetic particles tagged to the biomaterial of interest can be removed from a matrix using a magnetic field, but they do not agglomerate (i.e., they stay suspended) after removal of the field. A common use of superparamagnetic nanoparticles is for immunospecific cell separations (11-13). Typically, the nanoparticles are dispersed within the pores of larger microparticles. In the simplest (direct) method, the microparticles are coated with a monoclonal antibody for a cell-surface antigen. The antibody-tagged, superparamagnetic microparticles are then incubated with a solution containing the cells of interest. The microparticles bind to the surfaces of the desired cells, and these cells can then be collected in a magnetic field (13). Methods of this type have been used to isolate or remove numerous cell types, including lymphocytes (cells that control immune response) and tumor cells. In addition to loading microparticles with superparamagnetic nanoparticles, other examples of tagging the desired biomaterial with individual nanoparticles have been reported (12) (Figure 1). Figure 1. Schematic representation of cell separation using antibody-bound superparamagnetic nanoparticles.This approach has numerous advantages. Whereas bound microparticles can affect the viability of the selected cells, nanoparticles supposedly do not affect cell viability (12). In addition, as previously indicated, nanoparticles do not affect the extent of light scattering by the cell solution. The disadvantage of this approach is small magnetic moments of individual nanoparticles; however, this problem can be overcome by using a high-gradient magnetic field (12). MRI contrast agents. Superparamagnetic Fe3O4 nanoparticles are also useful as magnetic resonance imaging (MRI) contrast agents (14). MRI is essentially proton NMR done on tissue. Protons are excited with short pulses of radio frequency radiation; the free induction decay as they relax is measured and deconvoluted by means of a Fourier transform, which provides an image of the tissue that corresponds to proton density. Areas of high proton density, usually in the form of water or lipid molecules, have a strong signal and appear bright. Areas of bone or tendon, which have a low proton density because of the lack of water and lipids, have a weak signal and appear dark. Traditionally, a major limitation of MRI has been its inability to distinguish differences in soft tissue types (e.g., healthy parts of the liver from diseased lesions), as the relative proton densities can be very similar. Other regions, such as the bowel, are hard to image because air pockets and fecal matter make the proton density inconsistent (15). Various contrast agents have been developed to circumvent these imaging problems. Contrast agents work by changing the strength of the MRI signal at a desired location. For example, superparamagnetic contrast agents change the rate at which protons decay from their excited state to the ground state, allowing more effective decay through energy transfer to a neighboring nucleus. As a result, regions containing the superparamagnetic contrast agent appear darker in an MRI than regions without the agent. For instance, when superparamagnetic nanoparticles are delivered to the liver, healthy liver cells can uptake the particles; diseased cells cannot. Consequently, the healthy regions are darkened, although the diseased regions remain bright (16). Superparamagnetic particles have many advantages over other contrast agents. Unlike agents such as perfluorochemicals, oils, and fats, superparamagnetic particles are miscible with aqueous systems, which means they can mix with material in the bowel and be used in small volumes. Immiscible agents must be used in sufficient quantity to displace intestinal matter (15). This miscibility also allows them to be used intravenously. Compared with other magnetic contrast agents (e.g., gadolinium chelates), they are much more potent [as much as 50 times more effective per mole (16)]. Another advantage is that the particles do not pass the blood-brain barrier; thus, they are well suited for tracking blood flow in the brain (17). A novel use of these nanoparticles is tracking cells in vivo. Yeh and colleagues labeled rat T-cells with superparamagnetic Fe3O4 nanoparticles and inflamed the rat's testicles, which attracted the particle-attached T-cells and caused a decrease in the MRI signal from the testicles (18). Other applicationsNanogold particles have been used extensively as specific staining agents in biological electron microscopy (19). The small sizes of these particles (diameters as small as 1.4 nm) allow them to be physically close to the structures they stain; thus, such particles provide high resolution. Because the nanoparticles are gold, which has a high backscatter coefficient, they appear bright in a scanning electron microscope image. In contrast, the high density of gold makes them appear dark in a transmission electron microscope image. Site-specific staining is obtained by labeling the nanogold particles with antibodies directed against a protein in the region of interest. Antibody-labeled gold nanoparticles are commercially available, and unlabeled gold nanoparticles can also be purchased and labeled with a specific antibody by the investigator. Direct adsorption of proteins, such as enzymes, onto bulk metal surfaces frequently results in denaturation of the protein and loss of bioactivity. In contrast, when such proteins are adsorbed to metal nanoparticles, bioactivity is often retained (20), such as when antibody-labeled nanoparticles are used as electron microscopy stains, as discussed earlier. In another example, Crumbliss and co-workers found that they could adsorb redox enzymes to colloidal gold with no loss of enzymatic activity. The enzyme-covered nanoparticles were then electrodeposited onto platinum gauze or glassy carbon to make enzyme electrodes (20). In addition, Natan and co-workers found that cytochrome c retained reversible cyclic voltammetry when deposited onto 12-nm-diameter gold particles attached to a conductive substrate. In contrast, if the cytochrome c was deposited on larger surface features (aggregates of the gold nanoparticles), the cyclic voltammetry became quasireversible or irreversible, indicating denaturation of the protein (21). These results demonstrate another unique feature of metal nanoparticles--biocompatibility. The repulsive electrostatic forces that keep colloidal particles from aggregating also cause them to form crystalline colloidal arrays (CCAs) when concentrated in a very low ionic strength liquid (22). The periodicity of such CCAs is in the 100-1000 nm range, so that the arrays refract light in the visible region and thus appear colored. Asher and co-workers found that the periodicity of polystyrene CCAs can be varied after incorporating them into a swellable polymer gel. As the gel swells, the intercolloid distance increases, causing a red shift in the refraction maxima or color of the CCA. For example, a temperature-induced color change could be obtained by using a temperature-sensitive hydrogel as the CCA matrix (22) (Figure 2). Figure 2. Temperature tuning of Bragg
diffraction from a 125-
|
|
|
|